Here are two notable trials underlying these potential benefits: In a study involving 107 patients with alcohol (n = 47) or opiate (n = 60) withdrawal symptoms, DSIP was administered intravenously based on the hypothesis of its agonistic activity on opiate receptors
Kolovrat et al., 2020) appears as the specific effect of BPC 157 in ischemia/reperfusion (Vukojevic et al., 2018
Your provider will determine the appropriate injection route, dose, and frequency based on your health history, goals, and response to time
pubmed.ncbi.nlm.nih.gov/29782846 Chang CH, et al
Make sure any clinic you choose uses pharmaceutical-grade B12 and is staffed by licensed medical professionals
The consent must accurately characterize the compound as an unapproved bulk drug substance (not as an approved drug used off-label), the evidence base and its limitations, known and theoretical risks, alternatives considered, the monitoring plan, and the patients ability to decline or discontinue